Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin
Calcific aortic stenosis (CAS) and type 2 diabetes mellitus (T2DM) are related and often concomitant pathologies, accompanied by common comorbidities such as hypertension or dyslipidemia. Oxidative stress is one of the mechanisms that trigger CAS, and it can drive the vascular complications in T2DM....
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2023 |
| País: | España |
| Institución: | Universidad Autónoma de Madrid |
| Repositorio: | Biblos-e Archivo. Repositorio Institucional de la UAM |
| Idioma: | inglés |
| OAI Identifier: | oai:repositorio.uam.es:10486/718897 |
| Acceso en línea: | http://hdl.handle.net/10486/718897 https://dx.doi.org/10.3390/antiox12051024 |
| Access Level: | acceso abierto |
| Palabra clave: | antioxidant defense calcific aortic stenosis diabetes mellitus metformin oxidative stress Medicina |
| id |
ES_97d2ebb4fae0cc6de6f45e7b8335c9df |
|---|---|
| oai_identifier_str |
oai:repositorio.uam.es:10486/718897 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of MetforminCorbacho Alonso, NereaRodríguez Sánchez, ElenaSastre Oliva, TamaraMercado García, ElisaPerales Sánchez, InesJuarez Alia, CristinaLópez Almodovar, Luis F.Padial, Luis R.Tejerina, TeresaMourino Alvarez, LauraRuiz Hurtado, GemaBarderas, María G.antioxidant defensecalcific aortic stenosisdiabetes mellitusmetforminoxidative stressMedicinaCalcific aortic stenosis (CAS) and type 2 diabetes mellitus (T2DM) are related and often concomitant pathologies, accompanied by common comorbidities such as hypertension or dyslipidemia. Oxidative stress is one of the mechanisms that trigger CAS, and it can drive the vascular complications in T2DM. Metformin can inhibit oxidative stress, yet its effects have not been studied in the context of CAS. Here, we assessed the global oxidative status in plasma from patients with CAS, both alone and with T2DM (and under treatment with metformin), using multimarker scores of systemic oxidative damage (OxyScore) and antioxidant defense (AntioxyScore). The OxyScore was determined by measuring carbonyls, oxidized LDL (oxLDL), 8-hydroxy-20-deoxyguanosine (8-OHdG), and xanthine oxidase (XOD) activity. In contrast, the AntioxyScore was determined through the catalase (CAT) and superoxide dismutase (SOD) activity, as well as the total antioxidant capacity (TAC). Patients with CAS displayed enhanced oxidative stress compared to control subjects, probably exceeding their antioxidant capacity. Interestingly, patients with CAS and T2DM displayed less oxidative stress, possibly due to the benefits of their pharmacological therapy (metformin). Thus, reducing oxidative stress or enhancing antioxidant capacity through specific therapies could be a good strategy to manage CAS, focusing on personalized medicineThis study has been funded by the Instituto de Salud Carlos III through the projects PI18/00995, PI21/00384, PI20/00763, CPII20/00022, and FI18/00261 and co-funded by the European Union #1; the Sociedad Española de Cardiología 2020 #1, Grant PRB3 (IPT17/0019—ISCIIISGEFI/ERDF); SBPLY/19/180501/000226, SBPLY/21/180501/000078, SBPLY/21/180225/000035 funded by the Consejería de Educación Junta de Comunidades de Castilla-La Mancha (JCCM, cofunded by the European Regional Development Fund 2021-2027); and partially by the Spanish Society of Nephrology SEN/SENEFRO Foundation. These results are aligned with the Spanish initiative on the Human Proteome Project (SpHPP). #1 Laboratorio de Fisiopatología Vascular, Fundación del Hospital Nacional de Parapléjicos, Toledo, SpainMDPIDepartamento de FisiologíaFacultad de Medicina20232023-05-01research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10486/718897https://dx.doi.org/10.3390/antiox12051024reponame:Biblos-e Archivo. Repositorio Institucional de la UAMinstname:Universidad Autónoma de MadridInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositorio.uam.es:10486/7188972026-06-23T12:46:27Z |
| dc.title.none.fl_str_mv |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin |
| title |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin |
| spellingShingle |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin Corbacho Alonso, Nerea antioxidant defense calcific aortic stenosis diabetes mellitus metformin oxidative stress Medicina |
| title_short |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin |
| title_full |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin |
| title_fullStr |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin |
| title_full_unstemmed |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin |
| title_sort |
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin |
| dc.creator.none.fl_str_mv |
Corbacho Alonso, Nerea Rodríguez Sánchez, Elena Sastre Oliva, Tamara Mercado García, Elisa Perales Sánchez, Ines Juarez Alia, Cristina López Almodovar, Luis F. Padial, Luis R. Tejerina, Teresa Mourino Alvarez, Laura Ruiz Hurtado, Gema Barderas, María G. |
| author |
Corbacho Alonso, Nerea |
| author_facet |
Corbacho Alonso, Nerea Rodríguez Sánchez, Elena Sastre Oliva, Tamara Mercado García, Elisa Perales Sánchez, Ines Juarez Alia, Cristina López Almodovar, Luis F. Padial, Luis R. Tejerina, Teresa Mourino Alvarez, Laura Ruiz Hurtado, Gema Barderas, María G. |
| author_role |
author |
| author2 |
Rodríguez Sánchez, Elena Sastre Oliva, Tamara Mercado García, Elisa Perales Sánchez, Ines Juarez Alia, Cristina López Almodovar, Luis F. Padial, Luis R. Tejerina, Teresa Mourino Alvarez, Laura Ruiz Hurtado, Gema Barderas, María G. |
| author2_role |
author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Departamento de Fisiología Facultad de Medicina |
| dc.subject.none.fl_str_mv |
antioxidant defense calcific aortic stenosis diabetes mellitus metformin oxidative stress Medicina |
| topic |
antioxidant defense calcific aortic stenosis diabetes mellitus metformin oxidative stress Medicina |
| description |
Calcific aortic stenosis (CAS) and type 2 diabetes mellitus (T2DM) are related and often concomitant pathologies, accompanied by common comorbidities such as hypertension or dyslipidemia. Oxidative stress is one of the mechanisms that trigger CAS, and it can drive the vascular complications in T2DM. Metformin can inhibit oxidative stress, yet its effects have not been studied in the context of CAS. Here, we assessed the global oxidative status in plasma from patients with CAS, both alone and with T2DM (and under treatment with metformin), using multimarker scores of systemic oxidative damage (OxyScore) and antioxidant defense (AntioxyScore). The OxyScore was determined by measuring carbonyls, oxidized LDL (oxLDL), 8-hydroxy-20-deoxyguanosine (8-OHdG), and xanthine oxidase (XOD) activity. In contrast, the AntioxyScore was determined through the catalase (CAT) and superoxide dismutase (SOD) activity, as well as the total antioxidant capacity (TAC). Patients with CAS displayed enhanced oxidative stress compared to control subjects, probably exceeding their antioxidant capacity. Interestingly, patients with CAS and T2DM displayed less oxidative stress, possibly due to the benefits of their pharmacological therapy (metformin). Thus, reducing oxidative stress or enhancing antioxidant capacity through specific therapies could be a good strategy to manage CAS, focusing on personalized medicine |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023 2023-05-01 |
| dc.type.none.fl_str_mv |
research article http://purl.org/coar/resource_type/c_2df8fbb1 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10486/718897 https://dx.doi.org/10.3390/antiox12051024 |
| url |
http://hdl.handle.net/10486/718897 https://dx.doi.org/10.3390/antiox12051024 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:Biblos-e Archivo. Repositorio Institucional de la UAM instname:Universidad Autónoma de Madrid |
| instname_str |
Universidad Autónoma de Madrid |
| reponame_str |
Biblos-e Archivo. Repositorio Institucional de la UAM |
| collection |
Biblos-e Archivo. Repositorio Institucional de la UAM |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869414110962122752 |
| score |
15,812429 |